139 related articles for article (PubMed ID: 21912610)
21. Synthesis and Biological Evaluation of Novel Alkyl Amine Substituted Icariside II Derivatives as Potential Anticancer Agents.
Wu T; Li T; Kang YN; Liu L; Wang XM; Lan JS; Ding Y; Zhang T
Molecules; 2018 Aug; 23(9):. PubMed ID: 30150543
[TBL] [Abstract][Full Text] [Related]
22. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
Nakagawa-Goto K; Bastow KF; Chen TH; Morris-Natschke SL; Lee KH
J Med Chem; 2008 Jun; 51(11):3297-303. PubMed ID: 18473435
[TBL] [Abstract][Full Text] [Related]
23. New cytotoxic biflavones from
Liu LF; Sun HH; Tan JB; Huang Q; Cheng F; Xu KP; Zou ZX; Tan GS
Nat Prod Res; 2021 Mar; 35(6):930-936. PubMed ID: 31109181
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and anti-cancer activities of apigenin derivatives.
Zheng X; Yu L; Yang J; Yao X; Yan W; Bo S; Liu Y; Wei Y; Wu Z; Wang G
Med Chem; 2014; 10(7):747-52. PubMed ID: 24605779
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of antitumour (1H-1,2,3-triazol-4-yl)-4-hydroxycyclohexa-2,5-dien-1-ones by copper-catalysed Huisgen cycloadditions.
McCarroll AJ; Matthews CS; Wells G; Bradshaw TD; Stevens MF
Org Biomol Chem; 2010 May; 8(9):2078-84. PubMed ID: 20401384
[TBL] [Abstract][Full Text] [Related]
26. Synthetic flavonols and flavones: A future perspective as anticancer agents.
Shoaib M; Ghias M; Shah SWA; Ali N; Umar MN; - A; Rahman M; - S
Pak J Pharm Sci; 2019 May; 32(3):1081-1089. PubMed ID: 31278723
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic N-(fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides: structure-activity relationships and synergistic studies.
Yen CT; Wu CC; Lee JC; Chen SL; Morris-Natschke SL; Hsieh PW; Wu YC
Eur J Med Chem; 2010 Jun; 45(6):2494-502. PubMed ID: 20334960
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.
Rane RA; Sahu NU; Gutte SD; Mahajan AA; Shah CP; Bangalore P
Eur J Med Chem; 2013 May; 63():793-9. PubMed ID: 23584542
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of baicalein derivatives as potent antitumor agents.
Luo R; Wang J; Zhao L; Lu N; You Q; Guo Q; Li Z
Bioorg Med Chem Lett; 2014 Mar; 24(5):1334-8. PubMed ID: 24507925
[TBL] [Abstract][Full Text] [Related]
30. New Alkoxy Flavone Derivatives Targeting Caspases: Synthesis and Antitumor Activity Evaluation.
Moreira J; Ribeiro D; Silva PMA; Nazareth N; Monteiro M; Palmeira A; Saraiva L; Pinto M; Bousbaa H; Cidade H
Molecules; 2018 Dec; 24(1):. PubMed ID: 30602686
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antitumor evaluation of methyl spongoate analogs.
Jiang CS; Huang CG; Feng B; Li J; Gong JX; Kurtán T; Guo YW
Steroids; 2010 Dec; 75(13-14):1153-63. PubMed ID: 20728460
[TBL] [Abstract][Full Text] [Related]
32. Natural products hybrids: 3,5,4'-Trimethoxystilbene-5,6,7-trimethoxyflavone chimeric analogs as potential cytotoxic agents against diverse human cancer cells.
Hassan AHE; Choi E; Yoon YM; Lee KW; Yoo SY; Cho MC; Yang JS; Kim HI; Hong JY; Shin JS; Chung KS; Lee JH; Lee KT; Lee YS
Eur J Med Chem; 2019 Jan; 161():559-580. PubMed ID: 30396104
[TBL] [Abstract][Full Text] [Related]
33. Total synthetic protoapigenone WYC02 inhibits cervical cancer cell proliferation and tumour growth through PIK3 signalling pathway.
Chen YJ; Kay N; Yang JM; Lin CT; Chang HL; Wu YC; Fu CF; Chang Y; Lo S; Hou MF; Lee YC; Hsieh YC; Yuan SS
Basic Clin Pharmacol Toxicol; 2013 Jul; 113(1):8-18. PubMed ID: 23387868
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, Molecular Docking and Biological Evaluation of Novel Flavone Derivatives as Potential Anticancer Agents Targeting Akt.
Abo-Salem HM; Gibriel AA; El Awady ME; Mandour AH
Med Chem; 2021; 17(2):158-170. PubMed ID: 32141421
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, antimicrobial and anti-cancer activities of some new N-ethyl, N-benzyl and N-benzoyl-3-indolyl heterocycles.
El-Sawy ER; Mandour AH; Mahmoud K; Islam IE; Abo-Salem HM
Acta Pharm; 2012 Jun; 62(2):157-79. PubMed ID: 22750815
[TBL] [Abstract][Full Text] [Related]
37. Novel 4,5-dihydrospiro[benzo[c]azepine-1,1'-cyclohexan]-3(2H)-one derivatives as PARP-1 inhibitors: Design, synthesis and biological evaluation.
Li S; Li XY; Zhang TJ; Zhu J; Liu KL; Wang DP; Meng FH
Bioorg Chem; 2021 Jun; 111():104840. PubMed ID: 33780687
[TBL] [Abstract][Full Text] [Related]
38. Relationship between Antioxidant and Anticancer Activity of Trihydroxyflavones.
Grigalius I; Petrikaite V
Molecules; 2017 Dec; 22(12):. PubMed ID: 29215574
[TBL] [Abstract][Full Text] [Related]
39. Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo.
Chang HL; Su JH; Yeh YT; Lee YC; Chen HM; Wu YC; Yuan SS
Cancer Lett; 2008 Aug; 267(1):85-95. PubMed ID: 18430509
[TBL] [Abstract][Full Text] [Related]
40. Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance.
Zha GF; Qin HL; Youssif BGM; Amjad MW; Raja MAG; Abdelazeem AH; Bukhari SNA
Eur J Med Chem; 2017 Jul; 135():34-48. PubMed ID: 28431353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
